Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BRINP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
NCS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPNS3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBPJ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NEFL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VSTM2A-OT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TUBB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APOBEC3F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGB8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPS10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF560 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDC42EP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C11orf49 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OPRK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on